During the past decade, Cancer Centre of Southeastern Ontario at Kingston General Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 61 clinical trials were completed, i.e. on average, 338.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 16 clinical trials were completed. i.e. 533.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 37 trials, followed by "NCIC Clinical Trials Group" with 36 trials sponsored, "Children's Oncology Group" with 26 trials sponsored, "Canadian Cancer Trials Group" with 13 trials sponsored and "Ontario Clinical Oncology Group (OCOG)" with 13 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator and "North Central Cancer Treatment Group" with 9 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" are "Breast Cancer" (21 trials), "Prostate Cancer" (15 trials), "Lung Cancer" (14 trials), "Colorectal Cancer" (10 trials) and "Lymphoma" (10 trials). Many other conditions were trialed in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" in a lesser frequency.

Most popular intervention types in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" are "Drug" (146 trials), "Radiation" (58 trials), "Procedure" (39 trials), "Other" (32 trials) and "Biological" (31 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (40 trials), "cisplatin" (17 trials), "conventional surgery" (16 trials), "doxorubicin hydrochloride" (15 trials) and "cyclophosphamide" (14 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Centre of Southeastern Ontario at Kingston General Hospital" are 123 trials for "All" genders, 37 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Centre of Southeastern Ontario at Kingston General Hospital". undefined are not yet recruiting, 1 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 156 completed trials in Cancer Centre of Southeastern Ontario at Kingston General Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Centre of Southeastern Ontario at Kingston General Hospital, 14 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".